Viz.ai
The Senior Clinical Study Manager plans, monitors, and executes clinical research trials and pilots to demonstrate the real-world impact of Viz.ai's AI-enabled care pathways, focusing on Life Sciences partnerships and health system pilots. The role ensures sponsor oversight of sites in compliance with GCP and regulations while optimizing speed, quality, and cost. This position involves leading study management activities, collaborating with cross-functional teams, and driving evidence generation to advance patient outcomes and healthcare innovation.
Headquarters
San Francisco, California, United States
Company Size
201-500 employees
Founded
2016
Viz.ai is an AI-powered care coordination platform that uses FDA‑cleared algorithms to automatically analyze medical images and detect time‑sensitive conditions such as stroke, large vessel occlusion, pulmonary embolism, and intracranial hemorrhage. The platform instantly routes alerts, connects care teams, and automates clinical workflows across PACS, EHRs, and communication tools to accelerate diagnosis and treatment. Deployed in hospitals and health systems worldwide, Viz.ai combines computer vision, secure collaboration, and analytics to reduce time‑to‑treatment and improve patient outcomes.
Viz.ai Study Demonstrates 44% Reduction in Interfacility Stroke Transfer Times
14 hours ago
Salesforce launches Agentforce Health AI agents to cut healthcare paperwork, adding HealthEx, Verily and Viz.ai
11 hours ago
Viz.ai Names Jallel Harrati Chief Revenue Officer to Drive Enterprise AI Growth
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Viz.ai.
‘Every second counts’: New Viz.ai platform brings the entire heart attack team together
Oct 8, 2025